Reporting of Rurality, Deprivation, and Socioeconomic Characteristics in Cancer Clinical Trials: A Systematic
-
By
-
Joseph M. Unger
-
June 23, 2026
-
Clinical Scorecard: Assessment of Rurality, Socioeconomic Status, and Deprivation in Cancer Clinical Trials: A Systematic Review
At a Glance
| Category | Detail |
|---|
| Condition | Cancer Clinical Trials |
| Key Mechanisms | Geographic and socioeconomic factors influence cancer outcomes and trial representation. |
| Target Population | Patients with cancer, particularly from rural and deprived areas. |
| Care Setting | Cancer clinical research and trials. |
Key Highlights
- Rural patients experience worse cancer outcomes due to access and care limitations.
- Socioeconomic deprivation correlates with poorer survival rates in cancer patients.
- Diversity in clinical trial cohorts is essential for interpreting treatment benefits and risks.
- Regulatory guidance emphasizes the need for better representation in clinical trials.
- Reporting of geographic and socioeconomic factors in trials is often inadequate.
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Patients enrolled in randomized cancer clinical trials.
Access to standardized, protocol-guided therapy varies by socioeconomic status and geography.
Clinical Best Practices
- Ensure trial cohorts reflect the intended target populations.
- Improve reporting of geographic and socioeconomic factors in clinical trials.
- Adopt strategies to enhance diversity in trial participation.
Related Resources & Content
